eSense-Lab (ASX:ESE) to test terpenes against coronavirus

Health Care

ASX:ESE MCAP $9.180M

CEO, Itzik MizrahiSource: NAI Puget Sound Properties

• Life sciences company eSense-Lab (ESE) has signed an agreement with the Israeli Ministry of Health (MOH) to conduct a joint research project
• The company will test its proprietary TRP-ENV compound against a human coronavirus strain, to assess its antiviral properties
• eSense-Lab will conduct the research at the Central Virology lab within the Chaim Sheba Medical Centre, Israel’s largest hospital
• Final results of the research project should be available by November 2020
• eSense-Lab closed in the grey for 1.8 cents per share

Read the full article on The Market Herald here: https://themarketherald.com.au/esense-lab-asxese-to-test-terpenes-against-coronavirus-2020-09-01/